[Antimicrobial susceptibility testing in clinically relevant non-fermenting gram-negative bacilli: recommendations from the Antimicrobial Agents Subcommittee of the Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas, Asociación Argentina de Microbiología].

Autor: Radice M; Subcomisión de Antimicrobianos, Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas, Asociación Argentina de Microbiología, Ciudad Autónoma de Buenos Aires, Argentina., Marín M, Giovanakis M, Vay C, Almuzara M, Limansky A, Casellas JM, Famiglietti A, Quinteros M, Bantar C, Galas M, Kovensky Pupko J, Nicola F, Pasterán F, Soloaga R, Gutkind G
Jazyk: Spanish; Castilian
Zdroj: Revista Argentina de microbiologia [Rev Argent Microbiol] 2011 Apr-May; Vol. 43 (2), pp. 136-53.
DOI: 10.1590/S0325-75412011000200012
Abstrakt: This document contains the recommendations for antimicrobial susceptibility testing of the clinically relevant non-fermenting gram-negative bacilli (NFGNB), adopted after conforming those from international committees to the experience of the Antimicrobial Agents Subcommittee members and invited experts. This document includes an update on NFGNB classification and description, as well as some specific descriptions regarding natural or frequent antimicrobial resistance and a brief account of associated resistance mechanisms. These recommendations not only suggest the antimicrobial drugs to be evaluated in each case, but also provide an optimization of the disk diffusion layout and a selection of results to be reported. Finally, this document also includes a summary of the different methodological approaches that may be used for detection and confirmation of emerging b-lactamases, such as class A and B carbapenemases.
Databáze: MEDLINE